The Lip TV News: Neil Riordan, PhD on Exploring New Stem Cell Treatments for MS, Arthritis, Autism and More

Stem cell treatment and research towards curing illness–from multiple sclerosis to spinal injury–is detailed by Dr. Neil Riordan. The American medical industry, obstructions to research in the states, misconceptions about stem cells, and the details about the treatment process are explained–and we look at video of patient recovery and speculate at what the future could spell for stem cell treatment and research in this Lip News interview, hosted by Elliot Hill.

GUEST BIO:
Dr. Neil Riordan is the founder and Chairman of Medistem Panama, a leading stem cell laboratory and research facility – located in Panama City. His institute is at the forefront of research of the effects of adult stem cells on the course of several chronic diseases. Dr. Riordan has more than 60 scientific articles in international peer-reviewed journals. In the stem cell arena, he and his colleagues have published more than 20 articles on Multiple Sclerosis, Spinal Cord Injury, Heart Failure, Rheumatoid Arthritis.

Additional Tickets Released for Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical Trials in New York City May 17th, 2014

Additional Tickets Released for Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical Trials in New York City May 17th, 2014 (via PRWeb)

Stem Cell Institute is releasing additional tickets for its Adult Stem Cell Therapy Clinical Trials seminar on Saturday, May 17, 2014 in New York City at the New York Hilton Midtown from 1:00 pm to 4:00 pm. New York, NY (PRWEB) May 02, 2014 Stem Cell…

Stem Cell Institute Welcomes Special Guest Speaker Roberta F. Shapiro DO, FAAPM&R to Stem Cell Therapy Public Seminar in New York City

Stem Cell Institute Welcomes Special Guest Speaker Roberta F. Shapiro DO, FAAPM&R to Stem Cell Therapy Public Seminar in New York City May 17th, 2014 (via PRWeb)

The Stem Cell Institute located in Panama City, Panama, welcomes special guest speaker Roberta F. Shapiro, DO, FAAPM&R to its public seminar on umbilical cord stem cell therapy on Saturday, May 17, 2014 in New York City at the New York Hilton Midtown…

Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical Trials in New York City May 17th, 2014

New York, NY (PRWEB) April 09, 2014

The Stem Cell Institute, located in Panama City, Panama, will present an informational umbilical cord stem cell therapy seminar on Saturday, May 17, 2014 in New York City at the New York Hilton Midtown from 1:00 pm to 4:00 pm.

Speakers include:

Neil Riordan PhD“Clinical Trials: Umbilical Cord Mesenchymal Stem Cell Therapy for Autism and Spinal Cord Injury”

Dr. Riordan is the founder of the Stem Cell Institute and Medistem Panama Inc.

Jorge Paz-Rodriguez MD“Stem Cell Therapy for Autoimmune Disease: MS, Rheumatoid Arthritis and Lupus”

Dr. Paz is the Medical Director at the Stem Cell Institute. He practiced internal medicine in the United States for over a decade before joining the Stem Cell Institute in Panama.

Light snacks will be served afterwards. Our speakers and stem cell therapy patients will also be on hand to share their personal experiences and answer questions.

Admission is free but space in limited and registration is required. For venue information and to register and reserve your tickets today, please visit: http://www.eventbrite.com/e/stem-cell-institute-seminar-tickets-11115112601 or call Cindy Cunningham, Patient Events Coordinator, at 1 (800) 980-7836.

About Stem Cell Institute Panama
Founded in 2007 on the principles of providing unbiased, scientifically sound treatment options; the Stem Cell Institute (SCI) has matured into the world’s leading adult stem cell therapy and research center. In close collaboration with universities and physicians world-wide, our comprehensive stem cell treatment protocols employ well-targeted combinations of autologous bone marrow stem cells, autologous adipose stem cells, and donor human umbilical cord stem cells to treat: multiple sclerosis, spinal cord injury, osteoarthritis, rheumatoid arthritis, heart disease, and autoimmune diseases.

In partnership with Translational Biosciences, a subsidiary of Medistem Panama, SCI provides clinical services for ongoing clinical trials that are assessing safety and signs of efficacy for osteoarthritis, rheumatoid arthritis, and multiple sclerosis using allogeneic umbilical cord tissue-derived mesenchymal stem cells (hUC-MSC), autologous stromal vascular fraction (SVF) and hU-MSC-derived mesenchymal trophic factors (MTF). In 2014, Translation Biosciences expects to expand its clinical trial portfolio to include spinal cord injury, heart disease, autism and cerebral palsy.

To-date, SCI has treated over 2000 patients.

For more information on stem cell therapy:

Stem Cell Institute Website: https://www.celllmedicine.com

Stem Cell Institute
Via Israel & Calle 66
Plaza Pacific Office #2A
Panama City, Panama

About Medistem Panama Inc.
Since opening its doors in 2007, Medistem Panama Inc. has developed adult stem cell-based products from human umbilical cord tissue and blood, adipose (fat) tissue and bone marrow. Medistem operates an 8000 sq. ft. ISO 9001-certified laboratory in the prestigious City of Knowledge. The laboratory is fully licensed by the Panamanian Ministry of Health and features 3 class 10000 clean rooms, class 100 laminar flow hoods, and class 100 incubators.

Medistem Panama Inc.
Ciudad del Saber, Edif. 221 / Clayton
Panama, Rep. of Panama

Phone: +507 306-2601
Fax: +507 306-2601

About Translational Biosciences
A subsidiary of Medistem Panama Inc., Translational Biosciences was founded solely to conduct clinical trials using adult stem cells and adult stem cell-derived products.

Translational Biosciences webSite: http://www.translationalbiosciences.com

Email: trials(at)translationalbiosciences(dot)com

Umbilical Cord Stem Cells: Regeneration, Repair, Inflammation and Autoimmunity – Neil Riordan PhD (Part 2 of 2)

In part 2, Dr. Riordan discusses how mesenchymal stem cells can affect tissue repair in spinal cord injury and in heart failure; benefit to heart is not the actual MSCs modeling new tissue. It is due to the trophic effects of MSC secretions; In rats, severed spinal cords re-grew after MSCs were implanted but the human MSCs did not form new cord tissue. The trophic factors secreted by the MSCs enable the spinal cord to repair itself.; Trophic factors from MSCs modulate the immune system by blocking clonal expansion of cytotoxic T-cells; There are 35 ongoing clinical trials using mesenchymal stem cells for autoimmune diseases; Safety of donor MSCs; Every mother has MSCs from each baby she has carried; Mothers have a lower incidence of autoimmune disease; Lifespan of mothers increased linearly with each child up to 14; There are 85 ongoing clinical trials using donor MSCs. Allogeneic MSCs from bone marrow have been approved in Canada and New Zealand to treat graft vs. host disease; limbal cells used in corneal transplants are MSCs; MSCs are useful in preventing donated organ rejection; glioma growth was found to be inhibited by MSCs; MSCs eliminated breast cancer in rats.

Autologous bone marrow-derived cell therapy combined with physical therapy induces functional improvement in chronic spinal cord injury patients

Cell Transplant. 2013 Feb 26. [Epub ahead of print]

El-Kheir WA, Gabr H, Awad MR, Ghannam O, Barakat Y, Farghali HA, Maadawi ZM, Ewes I, Sabaawy HE.

Abstract

Spinal cord injuries (SCI) cause sensory loss and motor paralysis and are treated with physical therapy, but most patients fail to recover due to limited neural regeneration. Here we describe a strategy in which treatment with autologous adherent bone marrow cells is combined with physical therapy to improve motor and sensory functions in early-stage chronic SCI patients

In a phase I/II controlled single-blind clinical trial (clinicaltrials.gov identifier: NCT00816803), 70 chronic cervical and thoracic SCI patients with injury durations of at least 6 months were treated with either intrathecal injection(s) of autologous adherent bone marrow cells combined with physical therapy, or with physical therapy alone. Patients were evaluated with clinical examinations, electrophysiological somatosensory evoked potential, MRI imaging, and functional independence measurements.

Chronic cervical and thoracic SCI patients treated with autologous adherent bone marrow cells combined with physical therapy showed functional improvements over patients in the control group treated with physical therapy alone, and there were no cell therapy-related side effects. At 18 months posttreatment, 23 of the 50 cell therapy-treated cases (46 percent) showed sustained improvement using the American Spinal Injury Association (ASIA) Impairment Scale (AIS). Compared to those patients with cervical injuries, a higher rate of functional improvement was achieved in thoracic SCI patients with shorter durations of injury and smaller cord lesions.

Therefore, when combined with physical therapy, autologous adherent bone marrow cell therapy appears to be a safe and promising therapy for patients with chronic spinal cord injuries. Randomized controlled multicenter trials are warranted.

Stem cell therapy for spinal cord injury: Daniel Wiest

Stem cell therapy for spinal cord injury: Trish Stressman

Stem cell recipient Trish Stressman discusses her recovery from spinal cord injury after undergoing stem cell therapy at the Stem Cell Institute in Panama City, Panama. Ms. Stressman has regained control of her core and is now able to stand and walk with a walker.

I now have my abs, back, obliques, hip flexors, and glutes all contracting!

“My name is Trish Stressman. On May 26, 2007 I was in an ATV accident and suffered a burst fracture of my T-6 vertebrae, which left me with a bruised spinal cord. I was labeled a complete spinal cord injury with no movement or feeling below my T-6 injury line. Two years later I found out about Cell Medicine. I wish that I would have found out even earlier because it was great to have “hope” again. I went to Costa Rica for my stem cell treatment. The facilities there were great. They were very clean, professional, organized and modern. The Dr.’s at Cell Medicine and at the Cima Hospital were amazing. They always took lots of time with me and they truly cared about me and my recovery. I always felt safe and knew I could contact them at any time. The Physical Therapy there was also amazing. Within two months of getting the umbilical cord blood and my own bone marrow stem cells through intrathecal injections and IV’s I gained a lot. I now have my abs, back, obliques, hip flexors, and glutes all contracting! I am working now to bring them to full strength and they are almost there. I can stand for an hour now locking my own hips in place while not placing my hands on any support. My knees are not locking on their own yet but I hope to gain that back in the future.”

– Trish Stressman

Stem cell therapy for spinal cord injury: Juan Carlos Murillo

Juan Carlos Murillo is a commercial airline pilot who suffered spinal cord injuries in 4 separate areas of his spinal cord. Doctors told him that his injury was “complete” and that he would never walk again. After completing four rounds of stem cells at the Stem Cell Institute in Panama City, Panama, Juan Carlos is walking again, driving a car and has recently passed his commercial airline pilot physical examination. He expects to begin flying again for an airline within the next few months.

“The Stem Cell Institute states that stem cell therapy is not a miracle cure, but I think for us, the patients, our parents and all of our relatives, it is a miracle cure…”

UPDATE May 2011

Juan Carlos Murillo is a commercial airline pilot who suffered spinal cord injuries in 4 separate areas of his spinal cord. Doctors told him that his injury was “complete” and that he would never walk again. After completing four rounds of stem cells at the Stem Cell Institute in Panama City, Panama, Juan Carlos is walking again, driving a car and has recently passed his commercial airline pilot physical examination. He expects to begin flying again for an airline within the next few months.

“The Stem Cell Institute states that stem cell therapy is not a miracle cure, but I think for us, the patients, our parents and all of our relatives, it is a miracle cure…” – Juan Carlos Murillo

Before he received stem cells, from the waist down, Juan Carlos had no sensation, no movement and was suffering from significant neuropathic pain. He was classified a ASIA “A”. After his first course of stem cells in November 2008, his neuropathic pain was reduced on a scale of 1 to 10 from a 10 beforehand to a 3 afterwards.

His second course of stem cells in February 2009, Juan Carlos starting experiencing movement in his left leg and feeling in certain areas of his leg. He also started gaining muscle mass.
At the time of his third round in June 2009, Juan Carlo was driving an automatic car with his left leg and taking his first steps with a walker and crutches. He had about 80% sensitivity in his left leg.

Juan Carlos received his fourth round in November 2010. By that time, he had recovered his right leg and discontinued using crutches to walk. He was now able to walk with a cane and drive his manual transmission car. He now competes in 4×4 races.

He has now passed his commercial pilot physical. He has started flying again and expects to be employed once more as a commercial pilot within the next one or two months.

November 2010
I am a commercial pilot. On May 13th of 2008 was in a plane crash in the town of Cartago in Costa Rica. As a result of this accident I suffered a complete lesion at L1 and fracture of T12, L1 and L2. I had two surgeries in Costa Rica and one in Chile to stabilize my spine leaving me with 8 screws and 4 titanium rods from T11 to L3 and a titanium spacer for my L1 vertebrae. After this my condition did not improve. I had complete paralysis from the hips down, suffered from neuropathic pain, which on scale from 0 to 10, most commonly reached 10. After returning from my last surgery I was offered stem cell treatment with stem cells from umbilical cord which began in October 2008 with five intrathecal (lumbar puncture) injections. A few weeks after finishing this treatment my neuropathic pain become less common and mostly low-intensity. I also regained bladder control. I received a second treatment in February 2009 with 5 other applications. After this I began to notice changes in my legs with some muscle contractions and sensitivity in certain places. I continued my physical therapy and was able to have better contractions and started to regain strength and contractions in new places. I also regained my bowel function and sexual function. My last treatment was in June 2009 with five intrathecal and 2 intravenous injections of stem cells. After this treatment I could stand up and take a few steps on crutches because I had regained enough strength in my left leg and had already started to have movement in my right leg. As of this writing (October, 2010) I am able to walk without any aids or appliances. I have recovered almost 100% of my right leg and over 80% of my left leg. I have resumed my daily activities like driving and walking. I recently I passed my physical exam and now can fly again. In recent tests and pictures taken of my spinal column there is still a lesion at L1 but I continue walking. I am continuing to recover day by day while in the next few days I will go back for another treatment with the hope that I will be able to be as normal as possible.

Stem cell therapy for spinal cord injury: Dimitrija Krcoski

This is a spinal cord injury patient walking. He had a T8 injury and had been in a wheelchair for 10 years. This video was taken one month after receiving Adult Stem Cells. He received stem cells from umbilical cord blood and umbilical cord matrix.